Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Safety and efficacy of the COMBO bio-engineered stent in an all-comer PCI cohort: 1-Year final clinical outcomes from the MASCOT post-marketing registry.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Safety and efficacy of the COMBO bio-engineered stent in an all-comer PCI cohort: 1-Year final clinical outcomes from the MASCOT post-marketing registry.
Safety and efficacy of the COMBO bio-engineered stent in an all-comer PCI cohort: 1-Year final clinical outcomes from the MASCOT post-marketing registry. Int J Cardiol. 2019 05 15; 283:67-72.
View in:
PubMed
subject areas
Bioengineering
Bioengineering
Coronary Artery Disease
Coronary Artery Disease
Drug-Eluting Stents
Drug-Eluting Stents
Female
Female
Follow-Up Studies
Follow-Up Studies
Humans
Humans
Immunosuppressive Agents
Immunosuppressive Agents
Male
Male
Middle Aged
Middle Aged
Percutaneous Coronary Intervention
Percutaneous Coronary Intervention
Product Surveillance, Postmarketing
Product Surveillance, Postmarketing
Prosthesis Design
Prosthesis Design
Registries
Registries
Retrospective Studies
Retrospective Studies
Sirolimus
Sirolimus
Time Factors
Time Factors
Treatment Outcome
Treatment Outcome
authors with profiles
Usman Baber